Intra-Arterial Delivery of Bevacizumab after Blood-Brain Barrier Disruption for the Treatment of Recurrent Glioblastoma: Progression-Free Survival and Overall Survival

BACKGROUND: This prospective, single-center study assesses progression-free survival (PFS) and overall survival (OS) in patients with recurrent glioblastoma multiforme (GBM) treated with a single dose of superselective intra-arterial cerebral infusion (SIACI) of bevacizumab (BV) after blood-brain ba...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Burkhardt, Jan-Karl, Riina, Howard, Shin, Benjamin J., Christos, Paul, Kesavabhotla, Kartik, Hofstetter, Christoph P., Tsiouris, Apostolos John, Boockvar, John A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2011
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3743246/
https://ncbi.nlm.nih.gov/pubmed/22405392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.wneu.2011.05.056
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia